Key Points
- CEO insider sale: Kewaunee Scientific CEO Thomas David Hull III sold 884 shares on Dec. 29 at an average price of $38.01 for $33,600.84, trimming his stake to 35,835 shares (a 2.41% decrease) valued at about $1.36M.
- Additional recent sale: Hull also sold 1,000 shares on Dec. 22 at $39.00 for $39,000, indicating multiple insider sales in late December.
- Company fundamentals and outlook: KEQU has a $107.4M market cap, 52-week range of $30.33–$71.33 and a P/E of 9.49; it reported most recent quarterly EPS of $0.91 on $70.1M revenue (down from $1.01 a year earlier) and carries an average analyst rating of "Hold."
Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 884 shares of the company's stock in a transaction that occurred on Monday, December 29th. The stock was sold at an average price of $38.01, for a total value of $33,600.84. Following the sale, the chief executive officer directly owned 35,835 shares in the company, valued at $1,362,088.35. This trade represents a 2.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Thomas David Hull III also recently made the following trade(s):
- On Monday, December 22nd, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $39.00, for a total transaction of $39,000.00.
Kewaunee Scientific Price Performance
KEQU stock opened at $37.41 on Thursday. Kewaunee Scientific Corporation has a 52 week low of $30.33 and a 52 week high of $71.33. The firm has a market capitalization of $107.37 million, a P/E ratio of 9.49 and a beta of 0.61. The company has a fifty day simple moving average of $39.74 and a two-hundred day simple moving average of $46.92. The company has a quick ratio of 1.71, a current ratio of 2.48 and a debt-to-equity ratio of 0.81.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its earnings results on Wednesday, December 10th. The technology company reported $0.91 earnings per share (EPS) for the quarter. The firm had revenue of $70.10 million for the quarter. Kewaunee Scientific had a net margin of 4.11% and a return on equity of 22.39%. During the same quarter in the prior year, the company posted $1.01 earnings per share.
Hedge Funds Weigh In On Kewaunee Scientific
A number of large investors have recently bought and sold shares of the business. Bank of America Corp DE grew its position in Kewaunee Scientific by 2,605.9% in the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after acquiring an additional 443 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC purchased a new stake in shares of Kewaunee Scientific during the third quarter valued at $38,000. US Bancorp DE grew its holdings in shares of Kewaunee Scientific by 80.0% in the third quarter. US Bancorp DE now owns 900 shares of the technology company's stock worth $38,000 after purchasing an additional 400 shares during the last quarter. Raymond James Financial Inc. purchased a new position in Kewaunee Scientific in the 2nd quarter worth about $60,000. Finally, Wedbush Securities Inc. purchased a new position in Kewaunee Scientific in the 2nd quarter worth about $232,000. Hedge funds and other institutional investors own 32.69% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on KEQU. Weiss Ratings restated a "hold (c+)" rating on shares of Kewaunee Scientific in a report on Wednesday, October 8th. Wall Street Zen downgraded shares of Kewaunee Scientific from a "buy" rating to a "hold" rating in a research note on Saturday, December 13th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Kewaunee Scientific presently has an average rating of "Hold".
View Our Latest Report on KEQU
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.
The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
